GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » NonCurrent Deferred Liabilities

Genxone (WAR:GX1) NonCurrent Deferred Liabilities : zł0.00 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Genxone NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Genxone's non-current deferred liabilities for the quarter that ended in Mar. 2025 was zł0.00 Mil.

Genxone NonCurrent Deferred Liabilities Historical Data

The historical data trend for Genxone's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone NonCurrent Deferred Liabilities Chart

Genxone Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Genxone Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genxone NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Genxone's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genxone Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
WAR:PUR WAR:SCS WAR:RNT WAR:PHR WAR:RDG WAR:NNG VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX OCSE:GMAB XKRX:196170
Traded in Other Exchanges
N/A
Address
ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002
Website
https://www.genxone.eu
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone Headlines

No Headlines